Crowdsourcing may help to assess voice training in Parkinson’s: Study
Crowdsourcing — collecting data from large groups of individuals via the internet — could be used in clinical studies to…
Articles by Marisa Wexler, MS
App allows patients to scroll social media by doing facial exercises
Eurofarma and Dentsu Creative have teamed up to launch a new app that allows people with Parkinson’s…
PharmaTher seeks fast-track status for ketamine
PharmaTher Holdings has applied to the U.S. Food and Drug Administration (FDA) asking that ketamine be given fast-track designation…
AAN 2023: Poorly controlled disease’s long-term burden evaluated
Abbvie is funding a clinical trial called PROSPECT to assess how clinical outcomes and disease burden change over time for…
AAN 2023: Skin test ably detects alpha-synuclein clumps in trial
An assay using skin biopsies, called the Syn-One Test, was able to detect the alpha-synuclein protein that characterizes Parkinson’s…
AAN 2023: Targeted DBS in brain may work better in Parkinson’s
People with Parkinson’s disease given deep brain stimulation (DBS) targeting the right side…
AAN 2023: Blood pressure, asthma meds tied to lower Parkinson’s risk
People prescribed certain medications to treat asthma or high blood pressure are less likely to develop Parkinson’s disease, according…
AAN 2023: P2B001 controls symptoms with less sleepiness
The investigational combination therapy P2B001 was similar to Mirapex (pramipexole) at controlling symptoms of Parkinson’s disease in a clinical…
AAN 2023: Oral DopaFuse reduces Parkinson’s ‘off’ time in small study
DopaFuse, a continuous oral levodopa-carbidopa delivery system, led to more stable levels of medication in the blood and better…
AAN 2023: Apomorphine infusion pump SPN-830 reduces ‘off’ time
Most people with Parkinson’s disease treated with SPN-830, an apomorphine infusion pump, report improvement in their health status.